Hungary Archives - MEDIC NEST

Belgium Denmark France Germany Hungary Netherlands Norway Switzerland UKMICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

July 19, 2022by pcdata

Dates: 01/01/2019 31/03/2025 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) Keywords: liver cihrrosis; biomarker; clinical trial; ACLF; acute-on-chronic liver failure; OMICs; hepatology;...

Germany HungaryEstablishing the Hungarian Center of Excellence for Molecular Medicine in partnership with EMBL

July 19, 2022by pcdata

Dates: 01/04/2017 31/03/2025 Topic: Research Centre Project type: Preclinic Project target: Other Financing: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions Participating agents: HCEMM NONPROFIT KORLATOLT FELELOSSEGU TARSASAG Keywords: centre; molecular medicine; molecular biology Countries: Hungary; Germany Project page: Access page

Denmark France Hungary Latvia Norway Serbia Sweden Turkey UKFinding Endometriosis using Machine Learning

July 19, 2022by pcdata

Dates: 01/01/2021 31/12/2024 Topic: Tool Project type: Preclinic Medical Device Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.4.2. – Individual awareness and empowerment for self-management of health Participating agents: AARHUS UNIVERSITET Keywords: software; surgery; machine learning; endometriosis; uterus; app; OMICs; patient care Countries: Denmark; Hungary; UK; France; Latvia;...

Belgium Germany Hungary New ZealandDigitalized Clone for Personalized Medicine

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2024 Topic: Tool AI/Big Data Project type: Preclinic Project target: Endocrine disease Cardiovascular disease Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge Other Participating agents: BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM Keywords: critical care medicine; personalized medicine; productivity; in-silico; model; virtual reality Countries:...